RNRMarketResearch.com

In Vitro Diagnostic Market Global Forecast to 2017 and Competitive Landscape

Press Release   •   Sep 24, 2014 09:03 EDT

RNR presents analysis and discussion about In Vitro Diagnostic Market, its forecasts and more is now available in the global research report “In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017”. This report can be ordered at ReportsnReports.com.

The global in vitro disgnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market.

Complete report available at http://www.reportsnreports.com/reports/266706-in-vitro-diagnostic-ivd-market-instruments-reagents-data-management-systems-technique-immunoassay-clinical-chemistry-molecular-diagnostics-haematology-applications-diabetes-infectious-diseases-cancer-cardiology-systems-end-users-forecast-to-2017.html .

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Inquire for discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=266706 . (Original Price US $4650 for single user)


Table of Contents

1 Introduction

2 Executive Summary

3  Market Overview

4 Global Ivd Market, By Technique

5 Global Ivd Market, By Product Type

6 Global Ivd Market, By Application

7 Global Ivd Market, By End-User

8 Geographic Analysis

9 Competitive Landscape

10 Company Profiles

List Of Figures

Figure 1 Global In-Vitro Diagnostic Instrument & Reagents Market, By Technique, 2012 ($Million) 30

Figure 2 Role Of Ivd In Healthcare 34

Figure 3 In Vitro Diagnostics Market Segmentation 36

Figure 4 In Vitro Diagnostics Market—Drivers & Restraints 37

Figure 5 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2012 44

Figure 6 Ivd Market: Pestel Analysis 46

Figure 7 Global In Vitro Diagnostics Market Segmentation, By Technique 50

Figure 8 Global In Vitro Diagnostics Market, By Technique 51

Figure 9 Global In Vitro Diagnostics Market, By Geography, 2012 163

Figure 10 Key Growth Strategies, 2011 – 2013 241

Figure 11 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million) 280

Figure 12 Abbott Laboratories, Inc.: Market Strategy, 2011 – 2013 283

Figure 13 Alere, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million) 287

Figure 14 Alere, Inc.: Professional Diagnostics Revenue, By Segment, 2011 – 2012 ($Million) 288

Figure 15 Alere, Inc.: Market Strategy, 2011 – 2013 294

Figure 16 Arkray, Inc.: Market Strategy, 2011 - 2012 299

Figure 17 Bayer Ag: Total Revenue, By Segment, 2010 – 2012 ($Million) 303

Figure 18 Becton, Dickinson And Company: Total Revenue, By Segment, 2010 – 2012 ($Million) 307

Figure 19 Bd Diagnostics: Total Revenue, By Segment, 2010 – 2012 ($Million) 308

Figure 20 Becton, Dickinson And Company: Market Strategy, 2011 – 2013 310

Figure 21 Biomerieux: Total Revenue, By Segment, 2010 – 2011 ($Million) 314

Figure 22 Biomerieux: Market Strategy, 2011 – 2012 318

Figure 23 Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million) 322

Figure 24 Bio-Rad Laboratories, Inc.: Market Srategy, 2011 – 2013 326

Figure 25 Danaher Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million) 330

Figure 26 Danaher Corporation: Market Strategy, 2011 – 2013 335

Figure 27 Diagnostica Stago Sas: Market Strategy, 2011 – 2013 341

Figure 28 Diasorin S.P.A.: Total Revenue, By Technology, 2010 – 2012, ($Million) 345

Figure 29 Diasorin S.P.A,: Market Strategy, 2011 – 2013 347

Figure 30 Hologic, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million) 352

Figure 31 Hologic, Inc.: Market Srategy, 2011 – 2013 354

Figure 32 Horiba Ltd.: Total Revenue, By Segments, 2009 – 2011 357

Figure 33 Horiba, Ltd.: Market Strategy, 2011 - 2013 359

Figure 34 Johnson & Johnson: Total Revenue, By Segment, 2010 – 2012 ($Milllion) 362

Figure 35 Johnson & Johnson: Diagnostics Franchise Revenue, 2010 – 2012 ($Million) 363

Figure 36 Johnson & Johnson: Market Strategy, 2011 – 2013 366

Figure 37 Novartis Ag: Total Revenue, By Segment, 2010 – 2012 370

Figure 38 Novartis Ag: Market Stretegy, 2011 – 2013 372

Figure 39 Qiagen N.V.: Total Revenue, By Segment, 2010 – 2012 ($Million) 376

Figure 40 Qiagen N.V.: Market Srategy, 2011 - 2013 378

Figure 41 Roche Holdings: Diagnostics Revenue, By Segment, 2010 – 2012 ($Million) 382

Figure 42 Roche Holdings: Diagnostics Revenue, By Geography, 2010 – 2012 ($Million) 383

Figure 43 Roche Holdings: Market Strategy, 2011 – 2012 386

Figure 44 Siemens Ag: Total Revenue, By Segment, 2010 – 2012 ($Million) 391

Figure 45 Siemens Healthcare: Market Strategy, 2011 – 2013 396

Figure 46 Sysmex Corporation: Diagnostics Segment Revenue, 2010 – 2012 ($Million) 403

Figure 47 Sysmex Corporation: Market Strategy, 2011 – 2013 406

Figure 48 Thermo Fisher Scientific, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million) 410

Figure 49 Thermo Fisher Scientific, Inc.: Market Srategy, 2011 – 2013 414

Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=266706 . (This is a premium research report priced at US$ 4650 for single user PDF license).


About Us:

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time!